75% Gain
75% Gain From Bidding War As Pfizer Beats All Challengers
- Pfizer beats out competition for Medivation.
- Syngenta clears key deal hurdle.
- ACT buys CST.
More from Chris DeMuth Jr
The most important insight of the day
Get the Harvest Daily Digest newsletter.